CV Sciences (CVSI) Stock Price, News & Analysis

Company Overview

CV Sciences, Inc. is a life sciences company focused on hemp-derived cannabidiol (CBD) consumer products. The company develops, manufactures, and markets products under its PlusCBD brand, including CBD oils, softgels, gummies, capsules, topicals, and products formulated for pets.

PlusCBD products are positioned for use in areas such as general wellness, relaxation, sleep, and recovery. CV Sciences distributes its products through e-commerce channels and a network of retail outlets, primarily in the United States, subject to applicable regulations governing hemp-derived products and dietary supplements.

Founded in 2012, CV Sciences has historically focused on cannabinoid-based consumer health products and related research. The company has been led by Joseph Dowling, who has served as its chief executive officer. Its shares trade on the over-the-counter market under the symbol CVSI.

Key Stats

• Today's Range: $0.0140 to $0.0150
• 50-Day Range: $0.01 to $0.03
• 52-Week Range: $0.01 to $0.10
• Volume: 69,772 shs
• Average Volume: 820,161 shs
• Market Capitalization: $3.42 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CV Sciences Stock Analysis - MarketRank™

CV Sciences scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for CV Sciences.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

CV Sciences has a P/B Ratio of 1.47. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of CV Sciences has been sold short.

Short Interest Ratio / Days to Cover

CV Sciences has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CV Sciences has recently increased by 123.11%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CV Sciences does not currently pay a dividend.

Dividend Growth

CV Sciences does not have a long track record of dividend growth.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.01

News Sentiment

CV Sciences has a news sentiment score of 0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for CV Sciences this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CV Sciences insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.70% of the stock of CV Sciences is held by insiders.

Percentage Held by Institutions

CV Sciences has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/12/2021
• Today: 10/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CVSI
• Previous Symbol: NASDAQ:CVSI
• CIK: 1510964
• Web: www.cvsciences.com
• Phone: (866) 290-2157
• Fax: 619-876-4321
• Employees: 43
• Year Founded: 2016

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$960 thousand
• Net Margins: -15.74%
• Pretax Margin: -15.69%
• Return on Equity: -132.06%
• Return on Assets: -29.50%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.99
• Quick Ratio: 0.18

Sales & Book Value

• Annual Sales: $13.79 million
• Price / Sales: 0.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: 1.45

Miscellaneous

• Outstanding Shares: 235,690,000
• Free Float: 219,903,000
• Market Cap: $3.42 million
• Optionable: Not Optionable
• Beta: 0.43